These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7444943)

  • 41. Low membrane protein sulfhydrils but not G6PD deficiency predict ribavirin-induced hemolysis in hepatitis C.
    Grattagliano I; Russmann S; Palmieri VO; Jüni P; Bihl F; Portincasa P; Palasciano G; Lauterburg BH
    Hepatology; 2004 May; 39(5):1248-55. PubMed ID: 15122753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of silicate polymers on erythrocytes in presence and absence of complement.
    CHARACHE P; MacLEOD CM; WHITE P
    J Gen Physiol; 1962 Jul; 45(6):1117-43. PubMed ID: 13878239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement: substitution of the terminal component in immune hemolysis by 1,10-phenanthroline.
    Hadding U; Müller-Eberhard HJ
    Science; 1967 Jul; 157(3787):442-3. PubMed ID: 4165677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure.
    Cruz Silva MM; Madeira VM; Almeida LM; Custódio JB
    Biochim Biophys Acta; 2000 Mar; 1464(1):49-61. PubMed ID: 10704919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Requirement of cytoplasmic components for lidocaine-induced shape change in human erythrocytes.
    Nishiguchi E; Sindo J; Hamasaki N
    Biochim Biophys Acta; 1993 Mar; 1176(1-2):95-105. PubMed ID: 8452885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis.
    Bakács T; Tótpál K; Ringwald G; Yefenof E
    J Clin Lab Immunol; 1988 Feb; 25(2):53-8. PubMed ID: 3373517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitory effect of bilirubin on complement-mediated hemolysis.
    Arriaga SM; Mottino AD; Almará AM
    Biochim Biophys Acta; 1999 Dec; 1473(2-3):329-36. PubMed ID: 10594370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
    Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
    J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of antibodies to membrane skeletal proteins on the shape of erythrocytes and their ability to respond to shape-modulating agents. Important role of 4.1 protein in the determination/maintenance of the discoid shape of erythrocytes.
    Pestonjamasp KN; Mehta NG
    Exp Cell Res; 1995 Jul; 219(1):74-81. PubMed ID: 7628552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low pH-induced hemolysis of erythrocytes is related to the entry of the acid into cytosole and oxidative stress on cellular membranes.
    Ivanov IT
    Biochim Biophys Acta; 1999 Jan; 1415(2):349-60. PubMed ID: 9889396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemolysis and morphological changes in rat erythrocytes with mercurials.
    Tanaka R; Nakai K
    Jpn J Pharmacol; 1977 Jun; 27(3):413-9. PubMed ID: 916386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
    Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
    J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No influence of echinocytic shape transformation of erythrocytes on phagocytosis by autologous monocytes in vitro.
    Reinhart WH; Schlappritzi E; Baerlocher GM
    Acta Haematol; 1997; 97(3):132-6. PubMed ID: 9066707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
    Bauer J; Valet G
    J Immunol; 1983 Feb; 130(2):839-44. PubMed ID: 6848597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin degradation in human erythrocyte. Effects of reduced glutathione on insulin degradation by hemolysate.
    Bellomo G; Nicotera PL; Fratino P
    Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1660-5. PubMed ID: 7030365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effect of gallic acid and its esters on 2,2'-azobis(2-amidinopropane)hydrochloride (AAPH)-induced hemolysis and depletion of intracellular glutathione in erythrocytes.
    Ximenes VF; Lopes MG; Petrônio MS; Regasini LO; Silva DH; da Fonseca LM
    J Agric Food Chem; 2010 May; 58(9):5355-62. PubMed ID: 20397726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individual differences in the sensitivity of sheep erythrocytes to the hemolytic action of serum complement and hemolysin.
    Truszczyński M; Borkowska B; Kogut L
    Arch Immunol Ther Exp (Warsz); 1966; 14(3):306-10. PubMed ID: 5919646
    [No Abstract]   [Full Text] [Related]  

  • 58. Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.
    Subías Hidalgo M; Martin Merinero H; López A; Anter J; García SP; Ataúlfo Gonzalez-Fernández F; Forés R; Lopez-Trascasa M; Villegas A; Ojeda E; Rodríguez de Córdoba S
    Immunobiology; 2017 Feb; 222(2):363-371. PubMed ID: 27644115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tannin-mediated attachment of avidin to erythrocytes does not cause their lysis by complement].
    Muzykantov VR; Smirnov MD; Zal'tsman AB; Samokhin GP
    Biokhimiia; 1993 Jul; 58(7):1027-32. PubMed ID: 8364121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
    Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.